The p110γ isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites

被引:41
|
作者
Thomas, Molly S. [1 ]
Mitchell, Jason S. [1 ]
DeNucci, Christopher C. [1 ]
Martin, Amanda L. [1 ]
Shimizu, Yoji [1 ]
机构
[1] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol,Canc Ctr, Minneapolis, MN 55455 USA
关键词
inflammation; chemokines; leukocyte; activation; trafficking;
D O I
10.1189/jlb.0807561
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of PI-3K in leukocyte function has been studied extensively. However, the specific role of the p110 gamma isoform of PI-3K in CD4 T lymphocyte function has yet to be defined explicitly. In this study, we report that although p110 gamma does not regulate antigen- dependent CD4 T cell activation and proliferation, it plays a crucial role in regulating CD4 effector T cell migration. Nai r ve p110 gamma(-/-) CD4 lymphocytes are phenotypically identical to their wildtype ( WT) counterparts and do not exhibit any defects in TCR- mediated calcium mobilization or Erk activation. In addition, p110 gamma- deficient CD4 OT. II T cells become activated and proliferate comparably with WT cells in response to antigen in vivo. Interestingly, however, antigen- experienced, p110 gamma- deficient CD4 OT. II lymphocytes exhibit dramatic defects in their ability to traffic to peripheral inflammatory sites in vivo. Although antigen- activated, p110 gamma-deficient CD4 T cells express P- selectin ligand, beta 2 integrin, beta 1 integrin, CCR4, CXCR5, and CCR7 comparably with WT cells, they exhibit impaired Factin polarization and migration in response to stimulation ex vivo with the CCR4 ligand CCL22. These findings suggest that p110 gamma regulates the migration of antigen- experienced effector CD4 T lymphocytes into inflammatory sites during adaptive immune responses in vivo.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 50 条
  • [31] A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation
    Clayton, E
    Bardi, G
    Bell, SE
    Chantry, D
    Downes, CP
    Gray, A
    Humphries, LA
    Rawlings, D
    Reynolds, H
    Vigorito, E
    Turner, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06): : 753 - 763
  • [32] Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
    Brown, Jennifer R.
    Byrd, John C.
    Coutre, Steven E.
    Benson, Don M.
    Flinn, Ian W.
    Wagner-Johnston, Nina D.
    Spurgeon, Stephen E.
    Kahl, Brad S.
    Bello, Celeste
    Webb, Heather K.
    Johnson, Dave M.
    Peterman, Sissy
    Li, Daniel
    Jahn, Thomas M.
    Lannutti, Brian J.
    Ulrich, Roger G.
    Yu, Albert S.
    Miller, Langdon L.
    Furman, Richard R.
    BLOOD, 2014, 123 (22) : 3390 - 3397
  • [33] The role of the p110δ PI3-kinase isoform in inflammatory bowel disease
    Kok, Klaartje
    Pearce, Wayne P.
    Peppelenbosch, Maikel P.
    Vanhaesebroeck, Bart
    Hommes, Daan. W.
    GASTROENTEROLOGY, 2006, 130 (04) : A554 - A554
  • [34] Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
    Yamaguchi, Hideki
    Fukami, Kiyoko
    Sakai, Ryuichi
    CANCER RESEARCH, 2011, 71
  • [35] Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
    Yamaguchi, Hideki
    Yoshida, Shuhei
    Muroi, Emi
    Yoshida, Nachi
    Kawamura, Masahiro
    Kouchi, Zen
    Nakamura, Yoshikazu
    Sakai, Ryuichi
    Fukami, Kiyoko
    JOURNAL OF CELL BIOLOGY, 2011, 193 (07): : 1275 - 1288
  • [36] The p110δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells
    Okkenhaug, Klaus
    Patton, Daniel T.
    Bilancio, Antonio
    Garcon, Fabien
    Rowan, Wendy C.
    Vanhaesebroeck, Bart
    JOURNAL OF IMMUNOLOGY, 2006, 177 (08): : 5122 - 5128
  • [37] Targeting the phosphoinositide 3-kinase isoform p110δ impairs growth and survival in neuroblastoma cells
    Boller, Danielle
    Schramm, Alexander
    Doepfner, Kathrin T.
    Shalaby, Tarek
    von Bueren, Andre O.
    Eggert, Angelika
    Grotzer, Michael A.
    Arcaro, Alexandre
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1172 - 1181
  • [38] Expression of the phosphoinositide 3-kinase p110δ isoform and its clinicopathological significance in gastric cancer
    Ji, Byounghoon
    Lee, Hyoun Wook
    Lee, Eun Hee
    Park, Moon-Il
    Kim, Mee-Seon
    Kim, Kyungeun
    Roh, Mee Sook
    Kim, Seok-Hyun
    Ji, Jun Ho
    Kim, Kwang Min
    Oh, Jieun
    Kim, Yong Seok
    Choi, Seong Hee
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9415 - 9421
  • [39] CD28 OF T-LYMPHOCYTES ASSOCIATES WITH PHOSPHATIDYLINOSITOL 3-KINASE
    AUGUST, A
    DUPONT, B
    INTERNATIONAL IMMUNOLOGY, 1994, 6 (05) : 769 - 774
  • [40] The role of the p110δ PI3-kinase isoform in inflammatory bowel disease
    Kok, K.
    Pearce, W. P.
    Peppelenbosch, M. P.
    Vanhaesebroeck, B.
    Hommes, D. W.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A38 - A38